275 related articles for article (PubMed ID: 21057369)
1. Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.
Yang CP; Veltri MA; Anton B; Yaster M; Berkowitz ID
Pediatr Crit Care Med; 2011 Sep; 12(5):e195-9. PubMed ID: 21057369
[TBL] [Abstract][Full Text] [Related]
2. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
[TBL] [Abstract][Full Text] [Related]
3. Off-label medication use in an academic hospital pediatric critical care unit.
Hsu B; Brazelton T
WMJ; 2009 Oct; 108(7):343-8. PubMed ID: 19886581
[TBL] [Abstract][Full Text] [Related]
4. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Novak E; Allen PJ
Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
[TBL] [Abstract][Full Text] [Related]
5. [Medical prescriptions to premature and newborn infants in an Austrian neonatal intensive care unit].
Prandstetter C; Tamesberger M; Wagner O; Weissensteiner M; Wiesinger-Eidenberger G; Weidinger I; Lechner E
Klin Padiatr; 2009 Sep; 221(5):312-7. PubMed ID: 19707996
[TBL] [Abstract][Full Text] [Related]
6. Off-label use of medications in children undergoing sedation and anesthesia.
Smith MC; Williamson J; Yaster M; Boyd GJ; Heitmiller ES
Anesth Analg; 2012 Nov; 115(5):1148-54. PubMed ID: 22451593
[TBL] [Abstract][Full Text] [Related]
7. Drug use density in critically ill children and newborns: analysis of various methodologies.
Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
[TBL] [Abstract][Full Text] [Related]
8. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
[TBL] [Abstract][Full Text] [Related]
9. High-alert medications in the pediatric intensive care unit.
Franke HA; Woods DM; Holl JL
Pediatr Crit Care Med; 2009 Jan; 10(1):85-90. PubMed ID: 19057440
[TBL] [Abstract][Full Text] [Related]
10. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study.
Barr J; Brenner-Zada G; Heiman E; Pareth G; Bulkowstein M; Greenberg R; Berkovitch M
Am J Perinatol; 2002 Feb; 19(2):67-72. PubMed ID: 11938479
[TBL] [Abstract][Full Text] [Related]
11. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
Gavrilov V; Lifshitz M; Levy J; Gorodischer R
Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
[TBL] [Abstract][Full Text] [Related]
12. Off-label drug use in hospitalized children.
Shah SS; Hall M; Goodman DM; Feuer P; Sharma V; Fargason C; Hyman D; Jenkins K; White ML; Levy FH; Levin JE; Bertoch D; Slonim AD
Arch Pediatr Adolesc Med; 2007 Mar; 161(3):282-90. PubMed ID: 17339510
[TBL] [Abstract][Full Text] [Related]
13. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
14. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
Torres A
Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of sepsis in children with acute leukemia admitted to the pediatric intensive care unit.
Singer K; Subbaiah P; Hutchinson R; Odetola F; Shanley TP
Pediatr Crit Care Med; 2011 Nov; 12(6):649-54. PubMed ID: 21478790
[TBL] [Abstract][Full Text] [Related]
16. Impact of pediatric exclusivity on drug labeling and demonstrations of efficacy.
Wharton GT; Murphy MD; Avant D; Goldsmith JV; Chai G; Rodriguez WJ; Eisenstein EL
Pediatrics; 2014 Aug; 134(2):e512-8. PubMed ID: 25022732
[TBL] [Abstract][Full Text] [Related]
17. Canadian and US drug approval times and safety considerations.
Rawson NS; Kaitin KI
Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
[TBL] [Abstract][Full Text] [Related]
18. Intraosseous access in the setting of pediatric critical care transport.
Fiorito BA; Mirza F; Doran TM; Oberle AN; Cruz EC; Wendtland CL; Abd-Allah SA
Pediatr Crit Care Med; 2005 Jan; 6(1):50-3. PubMed ID: 15636659
[TBL] [Abstract][Full Text] [Related]
19. Off-label medication use in adult critical care patients.
Lat I; Micek S; Janzen J; Cohen H; Olsen K; Haas C
J Crit Care; 2011 Feb; 26(1):89-94. PubMed ID: 20716478
[TBL] [Abstract][Full Text] [Related]
20. IOM Review of FDA--approved biologics labeled or studied for pediatric use.
Field MJ; Ellinger LK; Boat TF
Pediatrics; 2013 Feb; 131(2):328-35. PubMed ID: 23319521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
